The Chicago Entrepreneur

FDA approves Moderna’s RSV vaccine for seniors, the company’s second-ever product

The decision is a win for Moderna, which needs another revenue source amid plunging demand for its Covid vaccine, its only commercially available product. 

Previous post Trump’s guilty verdicts make 34 cases for gold
Next post Pfizer’s drug for advanced lung cancer shows promising long-term trial results